Cardio-oncology in Turkey has grown over the past decade, focusing on the heart risks linked to advanced cancer treatments. With treatments like Trastuzumab, VEGF tyrosine inhibitors, and anthracycline-based chemotherapy improving cancer survival rates, they also pose potential cardiovascular toxicity. This growing need has led Turkey to establish specialized cardio-oncology services, offering comprehensive care to cancer...









